Medical Equipment

By integrating a (meth)acrylic modified polyester resin and polyurethane resin intermediate layer with a block copolymer, the medical device enhances sliding durability and flexibility, addressing the trade-off in existing technologies.

JP7591508B2Active Publication Date: 2024-11-28TERUMO KK
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
JP2021546930
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-09-17
Filing Date
2020-09-16
Publication Date
2024-11-28
Estimated Expiration
2040-09-16

AI Technical Summary

Technical Problem

Existing medical devices face a trade-off between maintaining lubricity and durability, particularly sliding durability, which is crucial for complex and prolonged medical procedures, necessitating a solution that enhances durability while preserving flexibility.

Method used

Incorporating an intermediate layer containing a (meth)acrylic modified polyester resin and a polyurethane resin between the base material and a surface lubricating layer, which includes a block copolymer with specific structural units, to improve adhesion and durability without compromising flexibility.

Benefits of technology

The solution achieves excellent sliding durability and maintains flexibility, reducing friction with body tissues and improving operability in complex medical procedures.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007591508000005
    Figure 0007591508000005
  • Figure 0007591508000006
    Figure 0007591508000006
  • Figure 0007591508000001
    Figure 0007591508000001
Patent Text Reader

Abstract

The present invention provides a means for improving the durability (sliding durability, in particular) of a surface lubrication layer of a medical instrument, while maintaining the flexibility of the instrument. This medical instrument comprises: a substrate in which a portion of the surface thereof is a polyester resin; a middle layer that is formed at least on a portion of the surface of the substrate and that includes a (meth)acrylic modified polyester resin and a polyurethane resin; and a surface lubricating layer that is formed on top of the middle layer and that includes a block copolymer having a structural unit (A) derived from hydrophobic monomers and a structural unit (B) derived from hydrophilic monomers. The hydrophobic monomers and / or the hydrophilic monomers have a (meth)acryloyl group.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to medical devices. [Background technology]

[0002] Medical devices inserted into the living body, such as catheters and guidewires, are required to exhibit excellent lubricity in order to reduce damage to tissues such as blood vessels and improve the operability of the surgeon. For this reason, a method for coating the surface of the base layer of a medical device with a hydrophilic polymer having lubricity has been developed and put into practical use. On the other hand, it is also important that such medical devices can maintain the hydrophilic polymer having lubricity on the surface of the base layer during use by the surgeon in order to maintain the operability of the surgeon. For this reason, the coating with a hydrophilic polymer is required to have not only excellent lubricity but also durability against loads such as wear and abrasion.

[0003] From this perspective, Japanese Patent Application Laid-Open No. 8-33704 discloses a medical device in which a water-soluble or water-swellable polymer is dissolved in a solvent in which the substrate of the medical device will swell to prepare a polymer solution, the substrate of the medical device is immersed in this polymer solution to cause it to swell, and the polymer is crosslinked or polymerized on the surface of the substrate layer, thereby forming a surface lubricating layer on the surface of the substrate layer.

[0004] According to the technique disclosed in Japanese Patent Laid-Open Publication No. 8-33704, it is disclosed that a surface lubricating layer exhibiting good lubricity can be fixed to a substrate. Summary of the Invention

[0005] JP-A-8-33704 discloses that it is preferable to use a block copolymer consisting of a hydrophilic part that exhibits lubricity and a part that has an epoxy group as a water-soluble or water-swellable polymer.When using such a block copolymer, the epoxy group of the block copolymer can be crosslinked by heating, and a surface lubricating layer that is relatively difficult to peel off can be formed.However, good lubricity and excellent durability are in a trade-off relationship, and a technology that can achieve both good lubricity and excellent durability is required.

[0006] In particular, in recent years, medical procedures in which medical tools approach more flexible and narrow lesion sites in living bodies are becoming more widespread. In addition, as medical procedures become more complicated, the operation of medical tools may take a long time. Therefore, in order to maintain good operability of the device even in complex lesion sites, a technology is required that further improves the lubrication maintenance (durability) of the device surface compared to the past. More specifically, there is a demand for a device that maintains flexibility and has excellent sliding durability, which can maintain high lubricity even when the device surface is repeatedly slid.

[0007] Therefore, there is a demand for technology that can improve the durability (especially sliding durability) of medical devices while maintaining their flexibility, and support increasingly complex and sophisticated medical procedures.

[0008] The present invention has been made in consideration of the above circumstances, and aims to provide a means for improving the durability (especially sliding durability) of a surface lubricating layer while maintaining the flexibility of a medical device.

[0009] The present inventor has conducted extensive research to solve the above problems. As a result, the inventor has found that the above object can be achieved by providing an intermediate layer containing (meth)acrylic modified polyester resin and polyurethane resin between a substrate, the surface of which is partly made of polyester resin, and a surface lubricating layer, and has completed the present invention.

[0010] That is, the above-mentioned object is achieved by a medical device comprising a substrate, a portion of whose surface is made of polyester resin, an intermediate layer formed on at least a portion of the surface of the substrate and containing a (meth)acrylic-modified polyester resin and a polyurethane resin, and a surface lubricating layer formed on top of the intermediate layer and containing a block copolymer having a structural unit (A) derived from a hydrophobic monomer and a structural unit (B) derived from a hydrophilic monomer, wherein at least one of the hydrophobic monomer and the hydrophilic monomer has a (meth)acryloyl group. [Brief description of the drawings]

[0011] [Figure 1] Fig. 1 is a schematic diagram of the friction tester used in the examples. In Fig. 1, 12 represents a petri dish, 13 represents an SEBS terminal, 14 represents a load, 15 represents a moving table, 16 represents a tube, 17 represents ion-exchanged water, 18 represents a core material, and 20 represents the friction tester. [Diagram 2] FIG. 2 is a schematic diagram of the tube used in the sliding durability test. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0012] Hereinafter, embodiments of the present invention will be described. Note that the present invention is not limited to the following embodiments.

[0013] The medical device according to one embodiment of the present invention comprises a substrate whose surface is partly polyester resin, an intermediate layer formed on at least part of the surface of the substrate, which comprises (meth)acrylic modified polyester resin and polyurethane resin, and a surface lubricating layer formed on the upper part of the intermediate layer, which comprises a block copolymer having a structural unit (A) derived from a hydrophobic monomer and a structural unit (B) derived from a hydrophilic monomer, and at least one of the hydrophobic monomer and the hydrophilic monomer has a (meth)acryloyl group.The medical device of the present invention having such a structure has excellent durability (especially sliding durability) of the surface lubricating layer while maintaining flexibility.

[0014] The mechanism by which the medical device according to the present invention can exhibit excellent durability (sliding durability) of the surface lubricating layer while maintaining flexibility is believed to be as follows. Note that the present invention is not limited to the following presumed mechanism.

[0015] The block copolymer having a constituent unit derived from a monomer having a (meth)acryloyl group forming the surface lubricating layer exhibits swelling when contacted with body fluids or aqueous solvents, and therefore imparts lubricity (surface lubricity) to the medical device, thereby reducing friction with the lumen wall such as the blood vessel wall. Here, the (meth)acrylic modified polyester resin contained in the intermediate layer according to the present invention has high affinity with the polyester resin contained in the substrate surface, and also has high affinity with the block copolymer contained in the surface lubricating layer. In addition, the polyurethane resin contained in the intermediate layer has high polarity, and therefore has affinity with both the polyester resin contained in the substrate surface and the block copolymer contained in the surface lubricating layer. Therefore, by providing an intermediate layer containing these two types of resin between the substrate and the surface lubricating layer, it is considered that the adhesion between the substrate and the intermediate layer and the adhesion between the intermediate layer and the surface lubricating layer can be strengthened while maintaining the flexibility of the substrate containing the polyester resin, and the durability (sliding durability) of the surface lubricating layer can be improved. Therefore, the medical device according to the present invention has excellent durability (sliding durability) of the surface lubricating layer while maintaining flexibility.

[0016] Hereinafter, embodiments of the present invention will be described. Note that the present invention is not limited to the following embodiments. Also, the dimensional ratios in the drawings are exaggerated for the convenience of explanation and may differ from the actual ratios.

[0017] In addition, in this specification, the range "X to Y" includes X and Y and means "X or more and Y or less." Furthermore, unless otherwise specified, the operation and measurement of physical properties are performed under the conditions of room temperature (20 to 25°C) and relative humidity of 40 to 50% RH.

[0018] Furthermore, in this specification, "(meth)acrylate" includes both methacrylate and acrylate, "(meth)acryloyl group" includes both methacryloyl group and acryloyl group, and "(meth)acrylic" includes both methacryl and acrylic.

[0019] Below, the medical device will be described in detail for each of its constituent parts.

[0020] [Base material] The substrate used in the present invention has a surface partly made of polyester resin. The substrate having a surface partly made of polyester resin has good adhesion to an intermediate layer containing a (meth)acrylic modified polyester resin and a polyurethane resin.

[0021] Examples of polyester resins include aliphatic polyester resins such as polylactic acid, polycaprolactone, and polybutylene succinate, and aromatic polyester resins such as polyethylene terephthalate, polytrimethylene terephthalate, and polybutylene terephthalate.

[0022] In addition, polyester elastomer resins can also be used as the polyester resins according to the present invention. The polyester elastomer resins are preferably block copolymers containing crystalline hard segments and amorphous soft segments. Such polyester elastomer resins soften and become fluid when heated, and exhibit rubber-like elasticity when not heated.

[0023] The polyester elastomer may be a polyester-polyether type having a hard segment mainly made of an aromatic polyester resin and a soft segment mainly made of an aliphatic polyether, or a polyester-polyester type having a hard segment mainly made of an aromatic polyester resin and a soft segment mainly made of an aliphatic polyester.

[0024] The aromatic polyester resin contained in the hard segment is preferably polybutylene terephthalate, polyethylene terephthalate, or polytrimethylene terephthalate, and more preferably polybutylene terephthalate.

[0025] The soft segment of the polyester elastomer resin preferably contains an aliphatic polyether and / or an aliphatic polyester. Examples of the aliphatic polyether include polyethylene glycol, polypropylene glycol, poly(tetramethyleneoxy)glycol (polytetramethylene ether glycol), poly(hexamethyleneoxy)glycol, copolymers of ethylene oxide and propylene oxide, ethylene oxide addition polymers of polypropylene glycol, copolymer glycols of ethylene oxide and tetrahydrofuran, etc. Examples of the aliphatic polyester include poly(ε-caprolactone), polyenantholactone, polycaprylolactone, polybutylene adipate, polyethylene adipate, etc.

[0026] These polyester resins may be used alone or in combination of two or more kinds.

[0027] Polyester resins have toughness, which allows them to smoothly move along a guidewire even in complex lesions, and they also have kink resistance, which makes it difficult for the medical device to bend even in curved blood vessels even after the guidewire is pulled out. In particular, in the case of polyester elastomer resins, the substrate of the medical device has toughness due to the rigidity of the hard segment portions and the flexibility of the soft segment portions, which can further reduce elongation of the substrate due to pulling or twisting.

[0028] The polyester resin may be a synthetic product or a commercially available product, such as Pelprene (registered trademark) P type, S type, and EN type manufactured by Toyobo Co., Ltd., Hytrel (registered trademark) SB654 and SB704 manufactured by DuPont-Toray Co., Ltd., and Tefablock A series manufactured by Mitsubishi Chemical Corporation.

[0029] The substrate may contain other materials as long as the substrate contains polyester resin on a part of the surface thereof, such as metal materials, polymeric materials other than polyester resin (resin materials or elastomer materials), and ceramics.

[0030] The metal material is not particularly limited, and metal materials generally used for medical devices such as catheters, introducers, guidewires, and indwelling needles are used. Specific examples include various stainless steels such as SUS304, SUS314, SUS316, SUS316L, SUS420J2, and SUS630, gold, platinum, silver, copper, nickel, cobalt, titanium, iron, aluminum, tin, and various alloys such as nickel-titanium alloys, nickel-cobalt alloys, cobalt-chromium alloys, and zinc-tungsten alloys. These metal materials may be used alone or in combination of two or more. The above-mentioned metal materials may be appropriately selected from metal materials that are optimal as the base material for medical devices such as catheters, introducers, guidewires, and indwelling needles, which are intended for use.

[0031] Furthermore, the polymeric material (resin material or elastomer material) other than polyester resin is not particularly limited, and may be a polymeric material generally used for medical devices such as catheters, introducers, guidewires, indwelling needles, etc. Specific examples include polyamide resins, polyolefin resins such as polyethylene resins and polypropylene resins, modified polyolefin resins, cyclic polyolefin resins, epoxy resins, polyurethane resins, diallyl phthalate resins (allyl resins), polycarbonate resins, fluororesins, amino resins (urea resins, melamine resins, benzoguanamine resins), styrene resins, acrylic resins, polyacetal resins, vinyl acetate resins, phenolic resins, vinyl chloride resins, silicone resins (silicon resins), polyether resins, polyimide resins, etc.

[0032] Thermoplastic elastomers such as polyurethane elastomers and polyamide elastomers can also be used as the material for the substrate.

[0033] These polymeric materials may be used alone, or may be a mixture of two or more of them, or a copolymer of two or more of the above resins or elastomers. The above polymeric materials may be appropriately selected from those that are optimal for the intended use of medical devices such as catheters, introducers, guidewires, and indwelling needles.

[0034] The shape of the substrate is not particularly limited, and may be appropriately selected depending on the mode of use, such as a sheet, a linear (wire), or a tubular (tube).

[0035] Here, the substrate may be entirely made of polyester resin. Also, if the substrate contains polyester resin in a part of the surface, it may be a multi-layer structure made of multiple layers of different materials, or may be a structure in which members made of different materials are joined for each part of the medical device. Furthermore, the substrate may have a structure in which the surface of the core of the substrate made of any of the above materials is coated with polyester resin and, if necessary, other materials by an appropriate method, so that the substrate contains polyester resin in a part of the surface.

[0036] [Middle layer] The intermediate layer is formed on at least a part of the substrate. Here, the intermediate layer may be formed on the whole or a part of the substrate, but is preferably formed on the area whose surface is made of polyester resin. In addition, other layers may be present between the substrate and the intermediate layer as long as they do not affect the effects of the present invention, but preferably, the intermediate layer is located directly above the substrate.

[0037] [(Meth)acrylic modified polyester resin] The intermediate layer according to the present invention contains a (meth)acrylic modified polyester resin. The (meth)acrylic modified polyester resin is a resin formed by chemically bonding a (meth)acrylic resin segment and a polyester resin segment. In this case, it is preferable that the (meth)acrylic resin segment and the polyester resin segment are bonded via a bireactive monomer.

[0038] <(Meth)acrylic resin segment> The (meth)acrylic polymerized segment constituting the (meth)acrylic modified polyester resin is composed of a resin obtained by polymerizing an addition polymerizable monomer including a (meth)acrylic monomer.

[0039] Examples of the (meth)acrylic monomer include (meth)acrylic acid ester monomers. Specific examples thereof include acrylic acid esters such as methyl acrylate, ethyl acrylate, n-propyl acrylate, isopropyl acrylate, n-butyl acrylate, isobutyl acrylate, t-butyl acrylate, n-pentyl acrylate, n-hexyl acrylate, n-octyl acrylate, 2-ethylhexyl acrylate, stearyl acrylate, dodecyl acrylate, n-behenyl acrylate, n-tricosanyl acrylate, glycidyl acrylate, and phenyl acrylate phenyl; methyl methacrylate, ethyl methacrylate, n-propyl acrylate, and the like. methacrylic acid esters such as n-butyl methacrylate, isopropyl methacrylate, n-butyl methacrylate, isobutyl methacrylate, t-butyl methacrylate, n-pentyl methacrylate, n-hexyl methacrylate, n-octyl methacrylate, 2-ethylhexyl methacrylate, stearyl methacrylate, dodecyl methacrylate, n-behenyl methacrylate, n-tricosanyl methacrylate, glycidyl methacrylate, phenyl methacrylate, diethylaminoethyl methacrylate, and dimethylaminoethyl methacrylate; acrylic acid, methacrylic acid, and the like.

[0040] Of these, n-butyl acrylate, methyl methacrylate, glycidyl methacrylate, and methacrylic acid are preferred.

[0041] These (meth)acrylic monomers may be used alone or in combination of two or more kinds.

[0042] The (meth)acrylic resin segment may have a structural unit derived from a general vinyl monomer in addition to the structural unit derived from the (meth)acrylic acid ester monomer described above. Examples of such vinyl monomers include olefins such as ethylene, propylene, and isobutylene; vinyl esters such as vinyl propionate, vinyl acetate, and vinyl benzoate; vinyl ethers such as vinyl methyl ether and vinyl ethyl ether; vinyl ketones such as vinyl methyl ketone, vinyl ethyl ketone, and vinyl hexyl ketone; N-vinyl compounds such as N-vinylcarbazole, N-vinylindole, and N-vinylpyrrolidone; vinyl compounds such as vinylnaphthalene and vinylpyridine; acrylonitrile, methacrylonitrile, and acrylamide.

[0043] In this specification, the content of the (meth)acrylic resin segment in the (meth)acrylic modified polyester resin, i.e., the ratio of the number of moles of the monomer constituting the (meth)acrylic resin segment to the total number of moles of the monomer constituting the (meth)acrylic resin segment and the monomer constituting the polyester resin segment, is defined as the "(meth)acrylic modification rate". This (meth)acrylic modification rate is preferably 5 to 70 mol%, more preferably more than 10 mol% to 60 mol% or less, and even more preferably 30 to 60 mol%. If it is within such a range, the adhesion between the intermediate layer and the surface lubricating layer is further improved. The (meth)acrylic modification rate is measured by subjecting the (meth)acrylic modified polyester resin to pyrolysis gas chromatography / mass spectrometry (Py-GC / MS), 1 It can be calculated by analysis using a method such as H-NMR.

[0044] <Polyester resin segment> The polyester resin segment constituting the (meth)acrylic modified polyester resin is composed of a polyester resin produced by carrying out a polycondensation reaction of a polyvalent carboxylic acid component and a polyhydric alcohol component in the presence of an esterification catalyst.

[0045] Specific examples of polyvalent carboxylic acid components include oxalic acid, succinic acid, maleic acid, adipic acid, β-methyladipic acid, azelaic acid, sebacic acid, nonanedicarboxylic acid, decanedicarboxylic acid, undecanedicarboxylic acid, dodecanedicarboxylic acid, fumaric acid, citraconic acid, diglycolic acid, cyclohexane-3,5-diene-1,2-dicarboxylic acid, malic acid, citric acid, hexahydroterephthalic acid, malonic acid, pimelic acid, tartaric acid, mucic acid, phthalic acid, isophthalic acid, terephthalic acid, tetrahydrophthalic acid, p-carboxyphenyl Examples of the dicarboxylic acids include acetic acid, p-phenylene diacetic acid, m-phenylenediglycolic acid, p-phenylenediglycolic acid, o-phenylenediglycolic acid, diphenylacetic acid, diphenyl-p,p'-dicarboxylic acid, naphthalene-1,4-dicarboxylic acid, naphthalene-1,5-dicarboxylic acid, naphthalene-2,6-dicarboxylic acid, anthracene dicarboxylic acid, and dodecenyl succinic acid; trimellitic acid, pyromellitic acid, naphthalene tricarboxylic acid, naphthalene tetracarboxylic acid, pyrene tricarboxylic acid, and pyrene tetracarboxylic acid. These polyvalent carboxylic acid components can be used alone or in combination of two or more.

[0046] Among these, it is preferable to use terephthalic acid. That is, it is preferable that the (meth)acrylic modified polyester resin according to the present invention contains terephthalic acid as a polyvalent carboxylic acid component. By containing terephthalic acid, the elastic modulus of the (meth)acrylic modified polyester resin becomes moderately large, and the adhesion between the substrate and the intermediate layer and the adhesion between the intermediate layer and the surface lubricating layer are further improved.

[0047] The content of the terephthalic acid-derived structural unit in the (meth)acrylic modified polyester resin is preferably 5 to 50 mol%, more preferably 10 to 45 mol%, more preferably 12.5 to 40 mol%, even more preferably 12.5 to 34 mol%, particularly preferably 13 to 34 mol%, and more particularly preferably 13 to 26 mol%, based on the total mole number of the monomer constituting the (meth)acrylic resin segment and the monomer constituting the polyester resin segment. If it is within such a range, the adhesion of the intermediate layer to the substrate and the adhesion of the surface lubricating layer to the intermediate layer are further improved.

[0048] In addition, the (meth)acrylic modified polyester resin preferably further contains isophthalic acid as a polyvalent carboxylic acid component. By containing isophthalic acid, the elastic modulus of the intermediate layer becomes appropriate, and the adhesion between the substrate and the intermediate layer and between the intermediate layer and the surface lubricating layer are further improved. In addition, the flexibility of the medical device is also easily maintained. When isophthalic acid is contained, the molar ratio of the constituent units derived from terephthalic acid to the constituent units derived from isophthalic acid in the (meth)acrylic modified polyester resin is preferably 1 or more and 5 or less, more preferably 1.5 or more and 4.5 or less, and even more preferably 1.8 or more and 4 or less. Within such a range, the adhesion between the substrate and the intermediate layer and the adhesion between the intermediate layer and the surface lubricating layer are further improved, and the durability (sliding durability) of the surface lubricating layer is more excellent. In addition, the flexibility of the medical device is also easily maintained, so that the medical device has excellent followability to the curved part.

[0049] The contents of terephthalic acid and isophthalic acid in the (meth)acrylic modified polyester resin were measured by pyrolysis gas chromatography / mass spectrometry (Py-GC / MS), 1 It can be calculated by analysis using a method such as H-NMR.

[0050] Specific examples of the polyhydric alcohol component include dihydric alcohols such as ethylene glycol, propylene glycol, 1,3-propanediol, 1,4-butanediol, diethylene glycol, neopentyl glycol, hexanediol, cyclohexanediol, octanediol, decanediol, dodecanediol, polytetramethylene ether glycol, ethylene oxide adduct of bisphenol A, and propylene oxide adduct of bisphenol A; trihydric or higher polyols such as glycerin and pentaerythritol. These polyhydric alcohol components can be used alone or in combination of two or more.

[0051] Among these, ethylene glycol, 1,3-propanediol, 1,4-butanediol, diethylene glycol, neopentyl glycol, and polytetramethylene ether glycol are preferred, and ethylene glycol, diethylene glycol, and neopentyl glycol are more preferred.

[0052] When a dihydric alcohol is used as the polyhydric alcohol component, the content of the structural unit derived from the dihydric alcohol component in the (meth)acrylic-modified polyester resin is preferably 5 to 55 mol %, and more preferably 10 to 50 mol %, relative to the total mole number of the monomer constituting the (meth)acrylic resin segment and the monomer constituting the polyester resin segment.

[0053] The content of the polyester resin segment in the (meth)acrylic modified polyester resin, i.e., the ratio of the number of moles of the monomer constituting the polyester resin segment to the total number of moles of the monomer constituting the (meth)acrylic resin segment and the monomer constituting the polyester resin segment, is preferably 30 to 95 mol%, more preferably 40 mol% or more and less than 90 mol%, and even more preferably 40 to 70 mol%. The content of the polyester resin segment in the (meth)acrylic modified polyester resin is also determined in the same manner as above by subjecting the (meth)acrylic modified polyester resin to pyrolysis gas chromatography / mass spectrometry (Py-GC / MS), 1 It can be calculated by analysis using a method such as H-NMR.

[0054] <Ambireactive monomer> The bireactive monomer is a monomer that bonds a (meth)acrylic resin segment and a polyester resin segment, and has, in the molecule, both a functional group capable of forming a polyester resin segment, such as a hydroxy group, a carboxy group, an epoxy group, a primary amino group, a secondary amino group, and the like, and an ethylenically unsaturated group capable of forming a (meth)acrylic resin segment. The bireactive monomer is preferably a monomer having a hydroxy group or a carboxy group and an ethylenically unsaturated group.

[0055] Specific examples of the bireactive monomer include compounds having a carboxy group and an ethylenically unsaturated group, such as acrylic acid, methacrylic acid, maleic acid, itaconic acid, cinnamic acid, fumaric acid, maleic acid monoalkyl ester, and itaconic acid monoalkyl ester; compounds having a hydroxy group and an ethylenically unsaturated group, such as 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, 3-hydroxypropyl (meth)acrylate, 2-hydroxybutyl (meth)acrylate, 3-hydroxybutyl (meth)acrylate, 4-hydroxybutyl (meth)acrylate, and polyethylene glycol mono(meth)acrylate. The polyester resin segment and the (meth)acrylic resin segment are bonded via this bireactive monomer. These bireactive monomers can be used alone or in combination of two or more.

[0056] Among these bireactive monomers, acrylic acid and methacrylic acid are preferred. In particular, methacrylic acid is more preferred from the viewpoint of improving the toughness of the (meth)acrylic-modified polyester resin. When methacrylic acid is used as the bireactive monomer, the polymer chain of methacrylic acid is likely to extend due to the influence of the steric hindrance of the methyl group of methacrylic acid, and the bond distance between the (meth)acrylic resin segment and the polyester resin segment is likely to become longer. Therefore, it is considered that the degree of freedom of the joint between the (meth)acrylic resin segment and the polyester resin segment is further improved, and the toughness of the (meth)acrylic-modified polyester resin is further improved. Therefore, it is considered that when methacrylic acid is used as the bireactive monomer, the medical device has improved followability to the curved parts of blood vessels and the like.

[0057] The content of the bireactive monomer-derived constitutional units in the (meth)acrylic-modified polyester resin is preferably 0.1 to 20 mol %, more preferably 1 to 10 mol %, based on the total number of moles of the monomers constituting the (meth)acrylic-modified polyester resin. The content of the bireactive monomer is measured by subjecting the (meth)acrylic-modified polyester resin to pyrolysis gas chromatography / mass spectrometry (Py-GC / MS), 1It can be calculated by analysis using a method such as H-NMR.

[0058] <Method of producing (meth)acrylic modified polyester resin> As a method for producing a (meth)acrylic modified polyester resin using a bireactive monomer, the following three methods can be preferably mentioned.

[0059] (1) A method for producing a (meth)acrylic-modified polyester resin by preliminarily polymerizing a polyester resin segment, reacting the polyester resin segment with a bireactive monomer, and further reacting the monomer that forms a (meth)acrylic resin segment.

[0060] (2) A method for producing a (meth)acrylic-modified polyester resin by preliminarily polymerizing a (meth)acrylic resin segment, reacting the (meth)acrylic resin segment with a bireactive monomer, and further reacting the (meth)acrylic resin segment with a polyvalent carboxylic acid and a polyhydric alcohol that form a polyester resin segment.

[0061] (3) A method in which a polyester resin segment and a (meth)acrylic resin segment are separately polymerized in advance, and then reacted with a bireactive monomer to bond the two segments.

[0062] As a catalyst for synthesizing the polyester resin segment, various conventionally known esterification catalysts can be used. The conditions for the esterification reaction are not particularly limited.

[0063] The method for producing the (meth)acrylic resin segment is not particularly limited, and examples thereof include a method in which polymerization is carried out by a known polymerization method such as bulk polymerization, solution polymerization, emulsion polymerization, mini-emulsion, or dispersion polymerization using a known oil-soluble or water-soluble polymerization initiator. If necessary, a known chain transfer agent may be used. The conditions for the polymerization reaction are also not particularly limited.

[0064] Other examples of the method for producing a (meth)acrylic-modified polyester resin include the following. That is, a method in which a polyvalent carboxylic acid having an ethylenically unsaturated group or a polyhydric alcohol having an ethylenically unsaturated group is used as a raw material monomer for a polyester resin segment, an ethylenically unsaturated group is introduced into the polyester resin segment, and an addition-polymerizable monomer including a (meth)acrylic monomer is addition-polymerized to the ethylenically unsaturated group portion. Alternatively, the resin may be produced by the method described in JP-A-2007-291546.

[0065] From the viewpoint of increasing the strength of the intermediate layer, the weight average molecular weight (Mw) of the (meth)acrylic modified polyester resin is preferably 10,000 or more. The weight average molecular weight (Mw) of the (meth)acrylic modified polyester resin can be measured by gel permeation chromatography (GPC) using polystyrene as a standard substance.

[0066] [Polyurethane resin] Polyurethane resins impart elasticity to medical devices, and therefore medical devices having intermediate layers containing polyurethane resins have good conformability even in highly flexible areas.

[0067] The polyurethane resin used in the present invention is not particularly limited, and for example, a polyurethane resin obtained by reacting (i) a component containing an average of two or more active hydrogen atoms per molecule with (ii) a polyisocyanate component can be used.

[0068] In addition, as the polyurethane resin, for example, a polyurethane resin produced by carrying out a urethane reaction of the above-mentioned (i) and (ii) components to obtain an isocyanate group-containing prepolymer, chain extending the prepolymer using a chain extender, and adding water to obtain a dispersion can be used. The prepolymer can be obtained by carrying out a urethane reaction of the above-mentioned (i) and (ii) components under conditions of an excess of isocyanate groups. The urethane reaction can be carried out in an organic solvent that is inert to the reaction and has a high affinity with water. Furthermore, the prepolymer may be neutralized before the chain extension of the prepolymer. In addition, as a method for chain extension of the isocyanate group-containing prepolymer, a known method of reacting the isocyanate group-containing prepolymer with a chain extender in the presence of a catalyst as necessary can be mentioned. In this case, as the chain extender, water, water-soluble polyamine, glycols, etc. are used.

[0069] The above-mentioned (i) component is preferably one having a hydroxyl group-type active hydrogen, for example, a compound having an average of two or more hydroxyl groups in one molecule. Specific examples of the (i) component include (1) a polyol compound, (2) a polyether polyol compound, (3) a polyester polyol compound, (4) a polyether ester polyol compound, and (5) a polycarbonate polyol compound. The compounds (1) to (5) are described below.

[0070] (1) Polyol compounds Examples of the polyol compound include ethylene glycol, propylene glycol, diethylene glycol, triethylene glycol, 1,2-butylene glycol, 1,3-butylene glycol, 2,3-butylene glycol, 1,4-butylene glycol, 1,5-pentanediol, neopentyl glycol, 1,6-hexane glycol, 2,5-hexanediol, dipropylene glycol, 2,2,4-trimethyl-1,3-pentanediol, tricyclodecane dimethanol, 1,4-cyclohexane dimethanol, 2,2-dimethylpropanediol, 1,4-butanediol, 1,6-hexanediol, 1,8-octamethylenediol, glycerin, trimethylolpropane, bisphenol A, bisphenol E, bisphenol F, phenol novolac, and cresol novolac.

[0071] (2) Polyether polyol compounds Examples of the polyether polyol compound include alkylene oxide adducts of the above (1) polyol compounds; ring-opening (co)polymers of alkylene oxides and cyclic ethers (e.g., tetrahydrofuran, etc.); polyethylene glycol, polypropylene glycol, copolymers of ethylene glycol and propylene glycol, copolymers of ethylene glycol and 1,4-butanediol, polytetramethylene glycol, polyhexamethylene glycol, polyoctamethylene glycol, and the like.

[0072] (3) Polyester polyol compound Examples of the polyester polyol compound include those obtained by polycondensing a polycarboxylic acid or its anhydride with the above (1) polyol compound under conditions of excess hydroxyl groups. Examples of the polycarboxylic acid include dicarboxylic acids such as adipic acid, succinic acid, sebacic acid, glutaric acid, maleic acid, fumaric acid, phthalic acid, isophthalic acid, and terephthalic acid; and tricarboxylic acids such as trimellitic acid. More specific examples of the polyester polyol compound include ethylene glycol-adipic acid condensate, butanediol-adipic acid condensate, hexamethylene glycol-adipic acid condensate, ethylene glycol-propylene glycol-adipic acid condensate, and polylactone diols obtained by ring-opening polymerization of lactones using glycol as an initiator.

[0073] (4) Polyether ester polyol compound Examples of the polyether ester polyol compound include those obtained by mixing an ether group-containing polyol or a mixture of the same with other glycols with a polyvalent carboxylic acid or its anhydride as exemplified in (3) above, and reacting the mixture with an alkylene oxide. Examples of the ether group-containing polyol include the polyether polyol (2) above and diethylene glycol. Specific examples of polyether ester polyol include polytetramethylene glycol-adipic acid condensate.

[0074] (5) Polycarbonate polyol compounds The polycarbonate polyol compound may, for example, be a compound represented by the general formula HO-R-(OC(O)-OR) X-OH (wherein, R represents a saturated fatty acid polyol residue having 1 to 12 carbon atoms, and x represents the number of repeating units and is usually an integer of 5 to 50). Polycarbonate polyol compounds can be obtained by a transesterification method in which a saturated aliphatic polyol is reacted with a substituted carbonate (e.g., diethyl carbonate, diphenyl carbonate, etc.) under conditions in which hydroxy groups are in excess; a method in which a saturated aliphatic polyol is reacted with phosgene and, if necessary, further reacted with a saturated aliphatic polyol; or the like.

[0075] The above component (i) can be used alone or in combination of two or more kinds.

[0076] From the viewpoint of enhancing the durability (toughness) of the intermediate layer, it is preferable that the polyurethane resin according to the present invention has a high elastic modulus. Therefore, the component (i) preferably contains a bisphenol such as bisphenol A, bisphenol E, or bisphenol F, and more preferably contains bisphenol A.

[0077] On the other hand, if the elastic modulus of the polyurethane resin according to the present invention is too high, the intermediate layer becomes brittle, and the adhesion between the substrate and the intermediate layer and between the intermediate layer and the surface lubricating layer may decrease. From this viewpoint, the elastic modulus of the polyurethane resin according to the present invention is preferably 250 to 800 MPa, more preferably 300 to 500 MPa.

[0078] The component (ii) (i.e., polyisocyanate component) to be reacted with the component (i) above may be, for example, a compound (polyisocyanate compound) containing an average of two or more isocyanate groups per molecule. This compound may be an aliphatic compound, an alicyclic compound, an aromatic compound, or an aromatic aliphatic compound.

[0079] Examples of the aliphatic polyisocyanate compound include trimethylene diisocyanate, tetramethylene diisocyanate, pentamethylene diisocyanate, hexamethylene diisocyanate, 1,2-propylene diisocyanate, 2,3-butylene diisocyanate, 1,3-butylene diisocyanate, dodecamethylene diisocyanate, and 2,4,4-trimethylhexamethylene diisocyanate.

[0080] Examples of alicyclic polyisocyanate compounds include 3-isocyanatemethyl-3,5,5-trimethylcyclohexyl isocyanate, 1,3-cyclopentane diisocyanate, 1,3-cyclohexane diisocyanate, 1,4-cyclohexane diisocyanate, methyl-2,4-cyclohexane diisocyanate, methyl-2,6-cyclohexane diisocyanate, 4,4'-methylenebis(cyclohexyl isocyanate), 1,4-bis(isocyanatemethyl)cyclohexane, and 1,4-bis(isocyanatemethyl)cyclohexane.

[0081] Examples of aromatic polyisocyanate compounds include 1,3-phenylene diisocyanate, 4,4'-diphenyl diisocyanate, 1,4-phenylene diisocyanate, 4,4'-diphenylmethane diisocyanate, 2,4-tolylene diisocyanate, 2,6-tolylene diisocyanate, 4,4'-toluidine diisocyanate, 2,4,6-triisocyanate toluene, 1,3,5-triisocyanate benzene, dianisidine diisocyanate, 4,4'-diphenyl ether diisocyanate, and 4,4',4"-triphenylmethane triisocyanate.

[0082] Examples of the aromatic aliphatic polyisocyanate compound include m-xylylene diisocyanate, ω,ω'-diisocyanate-1,3-dimethylbenzene, ω,ω'-diisocyanate-1,4-dimethylbenzene, ω,ω'-diisocyanate-1,4-diethylbenzene, 1,4-tetramethylxylylene diisocyanate, and 1,3-tetramethylxylylene diisocyanate.

[0083] The polyisocyanate compound is a diisocyanate compound, but a triisocyanate compound obtained by modifying the diisocyanate compound can also be used as component (ii). Examples of the triisocyanate compound include a trimethylolpropane adduct, a biuret, and a trimer (this trimer contains an isocyanurate ring) of the diisocyanate compound.

[0084] These components (ii) can be used alone or in combination of two or more.

[0085] In addition, as the polyurethane resin, commercially available water-based urethane resins may be used. Water-based urethane resins are compositions containing polyurethane resin and water, and are usually compositions in which polyurethane resin and optional components contained as necessary are dispersed in water. Examples of commercially available water-based urethane resins include the "ADEKA BONTITOR (registered trademark)" series manufactured by ADEKA Corporation, the "OLESTAR (registered trademark)" series manufactured by Mitsui Chemicals, Inc., the "BONDIC (registered trademark)" series and "HYDRAN (registered trademark)" series manufactured by DIC Corporation, the "IMPLANIL (registered trademark)" series manufactured by Bayer AG, the "SANPRENE (registered trademark)" series manufactured by Sanyo Chemical Industries, Ltd., the "SUPERFLEX" series and F-2170D manufactured by Daiichi Kogyo Seiyaku Co., Ltd., the "NEOREZ (registered trademark)" series manufactured by Kusumoto Chemicals Co., Ltd., and the "Sancure (registered trademark)" series manufactured by Lubrizol Japan Co., Ltd.

[0086] The polyurethane resins may be used alone or in combination of two or more kinds.

[0087] From the viewpoint of increasing the strength of the intermediate layer, the weight average molecular weight (Mw) of the polyurethane resin is preferably 10,000 or more. The weight average molecular weight (Mw) of the polyurethane resin can be measured by gel permeation chromatography (GPC) using polystyrene as a standard substance.

[0088] The mass ratio of the (meth)acrylic modified polyester resin to the polyurethane resin in the intermediate layer is preferably (meth)acrylic modified polyester resin / polyurethane resin=10 / 90 to 90 / 10, more preferably 70 / 30 to 30 / 70. Within this range, a medical device can be obtained in which the flexibility is maintained while the durability (sliding durability) of the surface lubricating layer is further improved.

[0089] <Other ingredients> The intermediate layer may contain other components in addition to the (meth)acrylic-modified polyester resin and polyurethane resin. The other components are not particularly limited, and examples thereof include silane coupling agents such as acrylic-modified silane coupling agents, inorganic fillers such as silica, reactive colloidal silica, polyvinyl compounds such as polyvinyl ether and polyvinyl alcohol, polyamide resins, and acrylic polyols.

[0090] [Method of forming intermediate layer] The method for forming the intermediate layer according to the present invention is not particularly limited, but preferably includes applying a solution containing a (meth)acrylic-modified polyester resin, a polyurethane resin, a solvent, and, as necessary, other components (also referred to simply as an "intermediate layer coating liquid" in this specification) onto a substrate ((Ia) solution application step, coating layer formation step), and drying the coating layer ((Ib) drying step).

[0091] (Ia) Solution coating process (coating layer forming process) In the method for forming an intermediate layer according to the present invention, first, a solution containing a (meth)acrylic-modified polyester resin, a polyurethane resin, a solvent, and other components as necessary is applied onto a substrate ((I) solution application step, coating layer formation step). The solution application step is performed for the purpose of supporting (or covering) an intermediate layer containing a (meth)acrylic-modified polyester resin and a polyurethane resin on the upper part of the substrate. The term "supported" means a state in which the intermediate layer is fixed in a state in which it is not easily detached from the substrate surface, and includes not only a form in which the entire substrate surface is completely covered with the intermediate layer, but also a form in which only a part of the substrate surface is covered with the intermediate layer, that is, a form in which the intermediate layer is attached to only a part of the substrate surface. Therefore, the method for applying the intermediate layer coating liquid is not particularly limited except for using a solution containing a (meth)acrylic-modified polyester resin, a polyurethane resin, and a solvent, and can be applied in the same manner as a known method or by appropriately modifying it.

[0092] In the solution coating process, specifically, a (meth)acrylic modified polyester resin, a polyurethane resin, and other components as necessary are dissolved in a solvent to prepare a solution (coating solution for intermediate layer), and the solution (coating solution) is coated onto a substrate to form a coating layer.

[0093] The solvent used in this step is not particularly limited as long as it can dissolve the (meth)acrylic modified polyester resin and polyurethane resin according to the present invention. Specifically, water, alcohols such as methanol, ethanol, 1-propanol, isopropanol, and ethylene glycol, ketones such as acetone, methyl ethyl ketone, and cyclohexanone, esters such as ethyl acetate, halides such as chloroform, olefins such as hexane, ethers such as tetrahydrofuran (THF) and butyl ether, aromatics such as benzene and toluene, amides such as N,N-dimethylformamide (DMF), and sulfoxides such as dimethyl sulfoxide can be exemplified, but are not limited thereto. These may be used alone or in combination of two or more. Among them, from the viewpoint of being able to uniformly dissolve the (meth)acrylic modified polyester resin and the polyurethane resin and to uniformly apply the solution, it is preferable to use water and alcohols in combination, and a mixed solvent of water and 1-propanol is particularly preferable.

[0094] <Preparation of intermediate layer coating solution> The above (meth)acrylic modified polyester resin, polyurethane resin, solvent, and other components as necessary are used to prepare the intermediate layer coating liquid. The order and method of adding each component are not particularly limited. The above components may be added all at once or separately, stepwise or continuously. The mixing method is also not particularly limited, and known methods can be used. A preferred method for preparing the intermediate layer coating liquid includes sequentially adding the (meth)acrylic modified polyester resin and the polyurethane resin to a solvent and stirring in the solvent.

[0095] The concentration of the (meth)acrylic modified polyester resin and polyurethane resin in the solution (intermediate layer coating solution) is not particularly limited. From the viewpoint of further improving the coating property, the concentration (solid content concentration) of the (meth)acrylic modified polyester resin and polyurethane resin in the coating solution is preferably 0.01 to 20 mass%, more preferably 0.05 to 15 mass%, and even more preferably 1 mass% or more and less than 15 mass%. If the concentration of the block copolymer is within the above range, the adhesion of the obtained intermediate layer can be fully exhibited. In addition, a uniform intermediate layer of a desired thickness can be easily obtained by one coating, and the viscosity of the solution is within an appropriate range, which is preferable in terms of operability (e.g., ease of coating) and production efficiency. However, even if it is out of the above range, it can be fully used as long as it is within a range that does not affect the effects of the present invention.

[0096] <Coating of intermediate layer coating solution> Next, after preparing the coating liquid for the intermediate layer as described above, the coating liquid is applied onto the substrate.

[0097] The method for applying (coating) the intermediate layer coating liquid to the substrate surface is not particularly limited, and any conventionally known method can be applied, such as a coating / printing method, an immersion method (dipping method, dip coating method), a spraying method (spray method), a spin coating method, a mixed solution-impregnated sponge coating method, a bar coating method, a die coating method, a reverse coating method, a comma coating method, a gravure coating method, or a doctor knife method.

[0098] When forming an intermediate layer on a thin and narrow inner surface of a catheter, injection needle, etc., the substrate may be immersed in the coating liquid and degassed by reducing the pressure in the system. By reducing the pressure and degassing, the solution can be quickly permeated into the thin and narrow inner surface, accelerating the formation of the intermediate layer.

[0099] Furthermore, when forming an intermediate layer only on a portion of the substrate, an intermediate layer can be formed on the desired surface portion of the substrate by immersing only a portion of the substrate in the coating liquid and coating the coating liquid onto the portion of the substrate.

[0100] In the case where it is difficult to immerse only a part of the substrate in the coating liquid, the surface portion of the substrate that does not need to form an intermediate layer is protected (coated, etc.) with a suitable removable (attachable) member or material in advance, and then the substrate is immersed in the coating liquid to coat the substrate with the coating liquid, and the protective member (material) of the surface portion of the substrate that does not need to form an intermediate layer is removed, and then a drying process or the like is performed to form an intermediate layer on a desired surface portion of the substrate. However, the present invention is not limited to these formation methods, and a conventionally known method can be appropriately used to form an intermediate layer. For example, in the case where it is difficult to immerse only a part of the substrate in the coating liquid, other coating methods (for example, a method of applying the coating liquid to a predetermined surface portion of a medical device using a coating device such as a spray device, a bar coater, a die coater, a reverse coater, a comma coater, a gravure coater, a spray coater, or a doctor knife) may be applied instead of the immersion method. When the structure of a medical device requires that both the outer and inner surfaces of the cylindrical device have an intermediate layer, the immersion method (dipping method) is preferably used since it allows coating of both the outer and inner surfaces at the same time.

[0101] The coating amount of the intermediate layer coating solution is preferably an amount that results in a coating (intermediate layer) having a thickness of 1 to 1000 nm, more preferably an amount that results in a coating (intermediate layer) having a thickness of 100 to 500 nm. With such a coating amount, the coating (intermediate layer) obtained can have sufficient adhesion to the substrate.

[0102] (Ib) Drying process In the method for forming an intermediate layer according to the present invention, it is preferable to carry out a drying step after forming a coating layer by applying a coating liquid for an intermediate layer onto a substrate.

[0103] The drying temperature is not particularly limited, but is preferably 10 to 200° C., and more preferably 25 to 150° C. The drying time is also not particularly limited, but is preferably 5 minutes to 5 hours, and more preferably 10 minutes to 3 hours.

[0104] The pressure conditions during drying are not limited, and drying can be performed under normal pressure (atmospheric pressure), or under pressure or reduced pressure. As the drying means (apparatus), for example, a drying furnace, an oven, a reduced pressure dryer, etc. can be used.

[0105] [Surface lubricant layer] The surface lubricating layer is formed on the upper part of the intermediate layer. Here, the surface lubricating layer may be formed only on the upper part of the intermediate layer provided on the part where the surface is required to have lubricity when wet. Of course, the surface lubricating layer may be provided so as to cover the entire intermediate layer.

[0106] The surface lubricating layer according to the present invention includes a block copolymer having a hydrophobic monomer-derived structural unit (A) and a hydrophilic monomer-derived structural unit (B). In this specification, the hydrophobic monomer-derived structural unit (A) is also simply referred to as a "hydrophobic monomer-derived structural unit" or "structural unit (A)". Similarly, the hydrophilic monomer-derived structural unit (B) is also simply referred to as a "hydrophilic monomer-derived structural unit" or "structural unit (B)". In addition, a block copolymer having a hydrophobic monomer-derived structural unit (A) and a hydrophilic monomer-derived structural unit (B) is also simply referred to as a "block copolymer".

[0107] [Block Copolymer] The surface lubricating layer according to the present invention includes a block copolymer having a structural unit (A) derived from a hydrophobic monomer and a structural unit (B) derived from a hydrophilic monomer. However, at least one of the hydrophobic monomer and the hydrophilic monomer has a (meth)acryloyl group. Such a block copolymer has excellent affinity with the (meth)acrylic-modified polyester resin and polyurethane resin contained in the intermediate layer, and the surface lubricating layer containing the block copolymer has higher adhesion to the intermediate layer. Therefore, the surface lubricating layer according to the present invention has excellent durability (sliding durability).

[0108] As described above, at least one of the hydrophobic monomer and the hydrophilic monomer has a (meth)acryloyl group. That is, the block copolymer is (a) A form in which the hydrophobic monomer has a (meth)acryloyl group and the hydrophilic monomer does not have a (meth)acryloyl group (b) A form in which the hydrophilic monomer has a (meth)acryloyl group and the hydrophobic monomer does not have a (meth)acryloyl group. (c) A form in which both the hydrophobic monomer and the hydrophilic monomer have a (meth)acryloyl group, and these can be used without limitation. However, from the viewpoint of further improving the effects of the present invention, the above form (c) is preferred.

[0109] <Hydrophobic monomer> The hydrophobic monomer constituting the block copolymer will be described below. In this specification, the term "hydrophobic monomer" refers to a compound that dissolves in an amount of 0.1 g or less in 100 g of water at 20°C.

[0110] The hydrophobic monomer may be used alone or in combination of two or more. That is, the hydrophobic unit (hydrophobic portion) derived from the hydrophobic monomer may be a homopolymer type composed of one hydrophobic monomer alone, or a copolymer type composed of two or more hydrophobic monomers. When two or more hydrophobic monomers are used, the form of the hydrophobic portion may be a block copolymer, a random copolymer, or an alternating copolymer.

[0111] The hydrophobic monomer constituting the block copolymer is not particularly limited as long as it satisfies the above definition, and known compounds can be used. Examples of such hydrophobic monomers include (meth)acrylic acid esters having a glycidyl group (epoxy group), such as glycidyl acrylate, glycidyl methacrylate (GMA), 3,4-epoxycyclohexylmethyl acrylate, 3,4-epoxycyclohexylmethyl methacrylate, β-methylglycidyl acrylate, and β-methylglycidyl methacrylate; methyl acrylate, methyl methacrylate, ethyl acrylate, ethyl methacrylate, isopropyl acrylate, isopropyl methacrylate, n-propyl acrylate, n-propyl methacrylate, n-butyl acrylate, Examples of monomers having a (meth)acryloyl group include (meth)acrylic acid esters having an alkyl group having 1 to 24 carbon atoms, such as n-butyl methacrylate (BuMA), 2-ethylhexyl acrylate, and 2-ethylhexyl methacrylate; (meth)acrylic acid esters having an aryl group having 6 to 20 carbon atoms, such as phenyl acrylate and phenyl methacrylate; (meth)acrylic acid esters having an aralkyl group having 7 to 30 carbon atoms, such as benzyl acrylate and benzyl methacrylate; and N-alkylacrylamides, such as N-tert-butylacrylamide and N-tert-butylmethacrylamide.

[0112] Hydrophobic monomers not having a (meth)acryloyl group, such as vinyl ethers having a glycidyl group (epoxy group) such as allyl glycidyl ether, olefins such as ethylene, propylene, isobutylene, vinyl chloride, vinylidene chloride, aromatic vinyls such as styrene, α-methylstyrene, and vinyl esters such as vinyl propionate, can also be used in the above form (b). Furthermore, if the hydrophobic unit (hydrophobic site) derived from the hydrophobic monomer is a copolymer type of a hydrophobic monomer having a (meth)acryloyl group and a hydrophobic monomer not having a (meth)acryloyl group, the hydrophobic monomer not having a (meth)acryloyl group can also be used in the above forms (a) and (c).

[0113] Among the above, it is preferable that the hydrophobic monomer includes at least one selected from the group consisting of glycidyl acrylate, glycidyl methacrylate, 3,4-epoxycyclohexylmethyl acrylate, 3,4-epoxycyclohexylmethyl methacrylate, β-methylglycidyl acrylate, β-methylglycidyl methacrylate; methyl acrylate, methyl methacrylate, n-butyl acrylate, n-butyl methacrylate, 2-ethylhexyl acrylate, 2-ethylhexyl methacrylate, benzyl acrylate, and benzyl methacrylate.

[0114] Furthermore, from the viewpoint of further improving the adhesion with the intermediate layer and further increasing the durability (sliding durability) of the surface lubricating layer, it is more preferable to include at least one selected from the group consisting of glycidyl acrylate, glycidyl methacrylate, 3,4-epoxycyclohexylmethyl acrylate, 3,4-epoxycyclohexylmethyl methacrylate, and β-methylglycidyl methacrylate. Particularly preferable is glycidyl acrylate or glycidyl methacrylate. These hydrophobic monomers have an epoxy group (glycidyl group), and the bias in the charge distribution of the epoxy group (glycidyl group) generates a cohesive force between the hydrophobic sites, which makes the polymer chains more likely to become entangled, which is thought to further improve the durability (sliding durability) of the surface lubricating layer.

[0115] <Hydrophilic monomer> The hydrophilic monomer will be described. In this specification, the term "hydrophilic monomer" refers to a compound that, when a block copolymer having the hydrophilic monomer and a constitutional unit derived from the hydrophobic monomer is prepared, the block copolymer has swelling properties when contacted with body fluids or aqueous solvents, and can impart lubricity (surface lubricity) to a medical device. By introducing such a constitutional unit (B) derived from a hydrophilic monomer into the block copolymer, the medical device can exhibit lubricity (surface lubricity), and the friction when the medical device comes into contact with a luminal wall such as a blood vessel wall can be reduced.

[0116] The hydrophilic monomer may be used alone or in combination of two or more. That is, the hydrophilic unit (hydrophilic moiety) derived from the hydrophilic monomer may be a homopolymer type composed of one hydrophilic monomer alone, or a copolymer type composed of two or more hydrophilic monomers. When two or more hydrophilic monomers are used, the form of the hydrophilic moiety may be a block copolymer, a random copolymer, or an alternating copolymer.

[0117] The hydrophilic monomer constituting the block copolymer is not particularly limited as long as it satisfies the above definition, and any known compound can be used. Examples of such hydrophilic monomers include monomers having a (meth)acryloyl group, such as acrylic acid, methacrylic acid, maleic acid; 2-acrylamido-2-methylpropanesulfonic acid; (meth)acryloyloxyethyl trimethylammonium salt, (3-acryloylaminopropyl) trimethylammonium salt, (3-methacryloylaminopropyl) trimethylammonium salt; N-methylacrylamide, N,N-dimethylacrylamide (DMAA), N-ethylacrylamide, acrylamide, N,N-diethylacrylamide (DEAA), N,N-dimethylaminopropylacrylamide, N,N-dimethylaminopropyl methacrylamide, N,N-dimethylaminoethyl acrylate, N,N-dimethylaminoethyl methacrylate, 2-hydroxyethyl acrylate, 2-hydroxyethyl methacrylate, 3-hydroxypropyl acrylate, 3-hydroxypropyl methacrylate, polyethylene glycol monoacrylate, polyethylene glycol monomethacrylate, alkoxypolyethylene glycol monoacrylate, and alkoxypolyethylene glycol monomethacrylate.

[0118] In addition, a hydrophilic monomer having no (meth)acryloyl group, such as N-vinyl-2-pyrrolidone, can also be used in the above-mentioned form (a). Furthermore, if the hydrophilic unit (hydrophobic portion) derived from the hydrophilic monomer is a copolymer type of a hydrophilic monomer having a (meth)acryloyl group and a hydrophilic monomer having no (meth)acryloyl group, the hydrophobic monomer having no (meth)acryloyl group can also be used in the above-mentioned forms (b) and (c).

[0119] Among the above, from the viewpoints of exerting excellent surface lubricity, further improving adhesion with the intermediate layer, and further increasing the durability (sliding durability) of the surface lubrication layer, it is preferable to include at least one selected from the group consisting of N,N-dimethylacrylamide, N,N-diethylacrylamide, acrylamide, 2-hydroxyethyl acrylate, and 2-hydroxyethyl methacrylate. As the hydrophilic monomer, N,N-dimethylacrylamide or N,N-diethylacrylamide is more preferable, and N,N-dimethylacrylamide is particularly preferable.

[0120] <Ratio of structural units (composition ratio)> The ratio (composition ratio) of the structural unit (A) to the structural unit (B) in the block copolymer is not particularly limited as long as the above-mentioned effects are exhibited. Considering good lubricity, lubrication maintenance, sliding properties, sliding durability, strength of the coating layer, adhesion to the base layer, etc., the ratio of the structural unit (A) to the structural unit (B) (molar ratio of structural unit (A): structural unit (B)) is preferably 1:2-100, more preferably 1:5-50, and even more preferably 1:10-20. Within such a range, the surface lubricating layer can fully exhibit lubricity, and the adhesion to the intermediate layer and sliding durability are further improved. The molar ratio of the structural unit (A): structural unit (B) can be controlled by adjusting the charge ratio (molar ratio) of each monomer in the production stage of the block copolymer. In this case, the charge ratio (molar ratio) of the hydrophobic monomer to the hydrophilic monomer in the production stage of the block copolymer is preferably 1:2 to 100, more preferably 1:5 to 50, and even more preferably 1:10 to 20. The molar ratio of the structural unit (A):structural unit (B) can be determined, for example, by NMR measurement of the copolymer ( 1 H-NMR measurement, 13 This can be confirmed by performing measurements such as C-NMR.

[0121] <Weight average molecular weight (Mw) of block copolymer> The weight average molecular weight of the block copolymer is not particularly limited, but is preferably 10,000 to 10,000,000 from the viewpoint of solubility. The weight average molecular weight of the block copolymer is more preferably 100,000 to 5,000,000 from the viewpoint of ease of preparation of a block copolymer solution (coating liquid for surface lubricant layer). The weight average molecular weight of the block copolymer is a value measured by gel permeation chromatography (GPC) using polystyrene as a standard substance.

[0122] <Method of producing block copolymer> The method for producing the block copolymer is not particularly limited, and can be produced by applying a conventionally known polymerization method such as a living radical polymerization method, a polymerization method using a macroinitiator, or a polycondensation method. Among these, a living radical polymerization method or a polymerization method using a macroinitiator is preferably used because it is easy to control the molecular weight and molecular weight distribution of the structural unit (part) derived from a hydrophobic monomer and the structural unit (part) derived from a hydrophilic monomer. The living radical polymerization method is not particularly limited, and can be applied in the same manner or with appropriate modification, for example, the methods described in JP-A-11-263819, JP-A-2002-145971, JP-A-2006-316169, and the like, as well as the atom transfer radical polymerization (ATRP) method. Furthermore, in a polymerization method using a macroinitiator, for example, a macroinitiator having a hydrophobic moiety having a hydrophobic functional group and a radically polymerizable group such as a peroxide group is prepared, and then the macroinitiator is polymerized with a monomer for forming a hydrophilic moiety (hydrophilic unit), thereby making it possible to prepare a block copolymer having a hydrophilic moiety (hydrophilic unit) and a hydrophobic moiety (hydrophobic unit).

[0123] In addition, in the polymerization of the block copolymer, known methods such as bulk polymerization, suspension polymerization, emulsion polymerization, and solution polymerization can be used. Specifically, in the production of the block copolymer, solution polymerization can be applied in which a hydrophobic monomer and a hydrophilic monomer are copolymerized by stirring and heating together with a polymerization initiator in a polymerization solvent. Here, the polymerization initiator is not particularly limited, and a known one may be used. In addition, the polymerization solvent is not particularly limited, and examples thereof include aliphatic organic solvents such as n-hexane, n-heptane, n-octane, n-decane, cyclohexane, methylcyclohexane, and liquid paraffin, ether solvents such as tetrahydrofuran and dioxane, aromatic organic solvents such as benzene, toluene, and xylene, halogen-based organic solvents such as 1,2-dichloroethane and chlorobenzene, and polar aprotic organic solvents such as N,N-dimethylformamide and dimethylsulfoxide. The polymerization solvent can be used alone or in a mixture of two or more kinds.

[0124] The monomer concentration (total concentration of hydrophilic monomer and hydrophobic monomer) in the polymerization solvent is preferably from 3 to 90 mass %, more preferably from 5 to 80 mass %, and particularly preferably from 8 to 50 mass %.

[0125] In the above polymerization, the polymerization conditions are also not particularly limited as long as the copolymerization proceeds. For example, the polymerization temperature is preferably 30 to 150° C., more preferably 40 to 100° C., and the polymerization time is preferably 30 minutes to 30 hours, more preferably 3 to 24 hours.

[0126] Furthermore, during the copolymerization, if necessary, a chain transfer agent, a polymerization rate regulator, a surfactant, a water-soluble polymer, a water-soluble inorganic compound (such as an alkali metal salt, an alkali metal hydroxide, a polyvalent metal salt, or a non-reducing alkali metal salt pH buffer agent), an inorganic acid, an inorganic acid salt, an organic acid or an organic acid salt, or other additives may be appropriately used.

[0127] After copolymerization, the block copolymer is preferably purified by a common purification method such as reprecipitation, dialysis, ultrafiltration, extraction, or the like.

[0128] <Other ingredients> The surface lubricating layer may contain other components in addition to the block copolymer. The other components are not particularly limited, and for example, when the medical device is intended to be inserted into a body cavity or a lumen such as a catheter, the other components may include anticancer drugs, immunosuppressants, antibiotics, antirheumatic drugs, antithrombotic drugs, HMG-CoA reductase inhibitors, ACE inhibitors, calcium antagonists, antihyperlipidemic drugs, integrin inhibitors, antiallergic drugs, antioxidants, GPIIb / IIIa antagonists, retinoids, flavonoids, carotenoids, lipid improving drugs, DNA synthesis inhibitors, tyrosine kinase inhibitors, antiplatelet drugs, vascular smooth muscle proliferation inhibitors, anti-inflammatory drugs, biological materials, interferons, and drugs (biologically active substances) such as NO production promoters. Here, the amount of the other components added is not particularly limited, and the amount normally used is applied in the same manner. Finally, the amount of the other components added is appropriately selected in consideration of the severity of the disease to which it is applied, the weight of the patient, and the like.

[0129] [Method of forming surface lubricating layer] The method for forming the surface lubricating layer of the present invention is not particularly limited, but preferably includes applying a solution containing a block copolymer having a structural unit (A) derived from a hydrophobic monomer and a structural unit (B) derived from a hydrophilic monomer and a solvent onto a substrate ((II-a) solution application step, coating layer formation step), and drying the coating layer ((II-b) drying step).

[0130] (II-a) Solution coating process (coating layer forming process) In the method for forming a surface lubricating layer according to the present invention, first, a solution containing the block copolymer and a solvent (also referred to as "coating liquid for surface lubricating layer" in this specification) is applied onto the intermediate layer ((I) solution application process, coating layer formation process). The solution application process is carried out for the purpose of supporting (or covering) a surface lubricating layer containing a block copolymer on the upper part of the intermediate layer. The term "support" means a state in which the surface lubricating layer is fixed in a state in which it is not easily detached from the surface of the intermediate layer, and includes not only a form in which the entire surface of the intermediate layer is completely covered with the surface lubricating layer, but also a form in which only a part of the surface of the intermediate layer is covered with the surface lubricating layer, that is, a form in which the surface lubricating layer is attached to only a part of the surface of the intermediate layer. Therefore, the method for applying the solution is not particularly limited except for using a solution containing a block copolymer having the above-mentioned structural unit (A) and structural unit (B) and a solvent, and can be applied in the same manner as a known method or by appropriately modifying it.

[0131] Specifically, in the solution coating process, the above-mentioned block copolymer is dissolved in a solvent to prepare a block copolymer solution (coating liquid for the surface lubricant layer), and the solution (coating liquid) is coated onto the intermediate layer to form a coating layer.

[0132] The solvent used to dissolve the block copolymer according to the present invention is not particularly limited as long as it can dissolve the block copolymer according to the present invention. Specifically, water, alcohols such as methanol, ethanol, isopropanol, and ethylene glycol, ketones such as acetone, methyl ethyl ketone, and cyclohexanone, esters such as ethyl acetate, halides such as chloroform, olefins such as hexane, ethers such as tetrahydrofuran (THF) and butyl ether, aromatics such as benzene and toluene, amides such as N,N-dimethylformamide (DMF), and sulfoxides such as dimethyl sulfoxide can be exemplified, but are not limited thereto. These may be used alone or in combination of two or more. Among them, from the viewpoint of being able to uniformly dissolve the block copolymer and to uniformly apply the coating liquid, the solvent of the coating liquid is preferably a ketone such as acetone, and an amide such as DMF, and particularly preferably acetone and DMF.

[0133] <Preparation of block copolymer solution (coating solution for surface lubricant layer)> The block copolymer solution (coating liquid for surface lubricating layer) is prepared using the block copolymer and the solvent. The order and method of adding the above components are not particularly limited. The above components may be added all at once or separately, stepwise or continuously. The mixing method is also not particularly limited, and known methods can be used. A preferred method for preparing the block copolymer solution (coating liquid) includes sequentially adding the block copolymer to a solvent and stirring in the solvent.

[0134] The concentration of the block copolymer in the block copolymer solution (coating solution for surface lubricant layer) is not particularly limited. From the viewpoint of further improving the coatability, lubricity and durability of the surface lubricant layer, the concentration of the block copolymer in the solution (coating solution) is preferably 0.01 to 20% by mass, more preferably 0.05 to 15% by mass, and even more preferably 1% by mass or more and less than 15% by mass. If the concentration of the block copolymer is within the above range, the lubricity and durability of the obtained surface lubricant layer can be fully exhibited. In addition, a uniform surface lubricant layer of the desired thickness can be easily obtained by one coating, and the viscosity of the solution is within an appropriate range, which is preferable in terms of operability (e.g., ease of coating) and production efficiency. However, even if it is out of the above range, it can be fully used as long as it is within a range that does not affect the effects of the present invention.

[0135] <Coating of block copolymer solution (coating liquid for surface lubricant layer)> Next, after preparing a solution (coating solution for surface lubricant layer) containing the block copolymer and the solvent as described above, the solution is applied onto the intermediate layer.

[0136] The method for applying (coating) the block copolymer solution (coating liquid for surface lubricant layer) to the surface of the intermediate layer is not particularly limited, and any conventionally known method can be applied, such as a coating / printing method, an immersion method (dipping method, dip coating method), a spraying method (spray method), a spin coating method, a mixed solution-impregnated sponge coating method, a bar coating method, a die coating method, a reverse coating method, a comma coating method, a gravure coating method, or a doctor knife method.

[0137] In addition, when forming a surface lubricating layer on a thin and narrow inner surface of a catheter, injection needle, etc., a substrate on which an intermediate layer has already been formed may be immersed in the coating liquid, and the system may be depressurized to degas the solution. By depressurizing and degassing the solution, the solution can be quickly permeated into the thin and narrow inner surface, accelerating the formation of the surface lubricating layer.

[0138] In addition, when forming a surface lubricant layer only on a portion of the intermediate layer, only a portion of the substrate on which the intermediate layer has been formed can be immersed in a coating liquid and the coating liquid can be coated onto a portion of the intermediate layer, thereby forming a surface lubricant layer on the desired surface portion of the intermediate layer.

[0139] In the case where it is difficult to immerse only a part of the substrate on which the intermediate layer has been formed in the coating liquid, the surface part of the intermediate layer on which it is not necessary to form a surface lubricating layer is protected (coated, etc.) with a suitable member or material that can be attached or detached in advance, and then the substrate on which the intermediate layer has been formed is immersed in the coating liquid to coat the intermediate layer with the coating liquid, and the protective member (material) of the surface part of the intermediate layer on which it is not necessary to form a surface lubricating layer is removed, and then a drying process or the like is performed to form a surface lubricating layer on the desired surface part of the intermediate layer. However, the present invention is not limited to these formation methods, and a surface lubricating layer can be formed by appropriately using a conventionally known method. For example, in the case where it is difficult to immerse only a part of the intermediate layer in the coating liquid, other coating methods (for example, a method of applying the coating liquid to a predetermined surface part of a medical device using a coating device such as a spray device, a bar coater, a die coater, a reverse coater, a comma coater, a gravure coater, a spray coater, or a doctor knife) may be applied instead of the immersion method. In addition, when the structure of a medical device requires that both the outer and inner surfaces of a cylindrical device have a surface lubricating layer, the immersion method (dipping method) is preferably used because it allows both the outer and inner surfaces to be coated at the same time.

[0140] The coating amount of the block copolymer solution (coating solution for surface lubricating layer) is preferably an amount that results in a thickness of 0.1 to 10 μm for the coating (surface lubricating layer), more preferably an amount that results in a thickness of 0.5 to 5 μm, and even more preferably an amount that results in a thickness of 1 to 3 μm. If the amount is within this range, even if the surface lubricating layer swells due to body fluid, the effect on the external shape of the medical device due to the increase in the thickness of the surface lubricating layer can be reduced. In particular, if the coating amount is such that the thickness of the coating (surface lubricating layer) is 10 μm or less, the blood vessel insertability can be improved for medical devices such as microcatheters that are inserted into thin blood vessels.

[0141] (II-b) Drying process In the method for forming a surface lubricant layer according to the present invention, it is preferable to apply a coating liquid for a surface lubricant layer onto a substrate to form a coating layer, and then carry out a drying step.

[0142] The drying temperature is not particularly limited, but is preferably from 10 to 200° C., and more preferably from 25 to 150° C. The drying time is also not particularly limited, but is preferably from 30 minutes to 30 hours, and more preferably from 1 to 25 hours.

[0143] The pressure conditions during drying are not limited, and drying can be performed under normal pressure (atmospheric pressure), or under pressure or reduced pressure. As the drying means (apparatus), for example, a drying furnace, an oven, a reduced pressure dryer, etc. can be used.

[0144] <Use of medical devices> The medical device according to the present invention is a device used in contact with body fluids, blood, etc., and has a lubricating surface in body fluids, physiological saline, and other aqueous liquids, thereby improving operability and reducing damage to tissues and mucous membranes. Specific examples include catheters, guidewires, indwelling needles, etc. used in blood vessels, but the following medical devices are also shown.

[0145] (a) Catheters that are inserted or left in the digestive tract via the mouth or nose, such as gastric catheters, nutritional catheters, and tube feeding tubes.

[0146] (b) Catheters that are inserted or placed in the airway or trachea via the mouth or nose, such as oxygen catheters, oxygen cannulas, endotracheal tubes and cuffs, tracheostomy tubes and cuffs, and endotracheal suction catheters.

[0147] (c) Catheters that are inserted or left in the urethra or ureter, such as urethral catheters, urinary catheters, and urethral balloon catheters.

[0148] (d) Catheters that are inserted or left in various body cavities, organs, or tissues, such as suction catheters, drainage catheters, and rectal catheters.

[0149] (e) Catheters that are inserted or left in blood vessels, such as indwelling needles, IVH catheters, thermodilution catheters, angiography catheters, vasodilator catheters, and dilators or introducers, as well as guide wires and stylets for these catheters.

[0150] (f) Artificial trachea, artificial bronchi, etc.

[0151] (g) Medical devices for extracorporeal circulation therapy (artificial lungs, artificial hearts, artificial kidneys, etc.) and their circuits.

[0152] The medical device according to the present invention is preferably a catheter. EXAMPLES

[0153] The effects of the present invention will be described using the following examples and comparative examples. However, the technical scope of the present invention is not limited to the following examples. In the following examples, unless otherwise specified, the operations were performed at room temperature (25°C). Furthermore, unless otherwise specified, "%" and "parts" mean "% by mass" and "parts by mass", respectively.

[0154] <Preparation of (meth)acrylic acid modified polyester resin> A (meth)acrylic modified polyester resin 1 (weight average molecular weight: 10,000 or more, hereinafter also simply referred to as “polyester resin 1”) having the following composition was prepared: Polyester resin segment Polycarboxylic acid component: 19 mol% terephthalic acid Isophthalic acid content: 6 mol% Polyhydric alcohol component: Content 25 mol% Monomers used Diethylene glycol:Ethylene glycol:Neopentyl glycol =11.8:10.3:2.9 (molar ratio) (Meth)acrylic resin segment (Meth)acrylic modification rate: 50 mol% Monomers used Methyl methacrylate:n-butyl acrylate:glycidyl methacrylate:methacrylic acid =27.0:13.5:5.5:4.0 (molar ratio) ·Ambient reactive monomer Methacrylic acid Amount used: 4.0 mol % based on the total number of moles of monomers constituting the (meth)acrylic modified polyester resin.

[0155] Similarly, (meth)acrylic-modified polyester resins 2 to 10 (hereinafter also referred to simply as "polyester resins 2 to 10") having the (meth)acrylic modification rates, terephthalic acid contents, isophthalic acid contents, and polyhydric alcohol component contents shown in Table 1 below, as well as unmodified polyester resin 11 that was not (meth)acrylic-modified, were prepared.

[0156] The types and amounts of the bireactive monomers, and the types and molar ratios of the monomers used in the polyhydric alcohol component and the (meth)acrylic resin segment are common to polyester resins 1 to 10 and unmodified polyester resin 11. The weight average molecular weights of polyester resins 1 to 10 and unmodified polyester resin 11 were all 10,000 or more.

[0157] [Table 1]

[0158] <Preparation of polyurethane resin> F-2170D (weight average molecular weight: 10,000 or more) manufactured by Daiichi Kogyo Seiyaku Co., Ltd. was prepared.

[0159] <Preparation of block copolymer> A diblock copolymer (structural unit (A):structural unit (B)=1 / 12 (molar ratio)) having glycidyl methacrylate (GMA) / N,N-dimethylacrylamide (DMAA)=1 / 12 (molar ratio) was prepared.

[0160] Example 1 <Sample preparation (formation of intermediate layer)> The resin components were dissolved in an aqueous 1-propanol solution (water / 1-propanol = 40 / 60 (mass ratio)) (stirring time: 1 minute) so that the mass ratio of polyester resin 1 to polyurethane resin was 70 / 30 and the total solid concentration of the resin components was 3 mass%, to prepare an intermediate layer coating liquid. Next, in an environment of 25°C and relative humidity 45%RH, a polyester tube (manufactured by Toyobo Co., Ltd., Pelprene (registered trademark) P40H, outer diameter 0.9 mm x length 600 mm) was immersed in the intermediate layer coating liquid and pulled up at a speed of 15 mm / sec to coat the intermediate layer coating liquid on the tube. Thereafter, the tube was dried for 10 minutes in a drying oven maintained at 100°C, to obtain tube 1-1 with an intermediate layer (dry film thickness: 150 nm) laminated thereon.

[0161] <Sample preparation (formation of surface lubricant layer)> The block copolymer was dissolved in acetone so that the concentration was 5% by mass (stirring time: 10 minutes) to prepare a coating solution for a surface lubricant layer. Next, in an environment of 25°C and relative humidity 45%RH, the tube 1-1 with the intermediate layer laminated thereon was immersed in the coating solution for a surface lubricant layer, and pulled up at a speed of 15 mm / sec to coat the coating solution for a surface lubricant layer on the tube 1-1. After that, the coated tube was dried for 2 hours in a drying oven maintained at 100°C to obtain a tube 1-2 with an intermediate layer and a surface lubricant layer (dry film thickness: 1.5 μm) laminated thereon.

[0162] Example 2 A tube 2-1 having an intermediate layer laminated thereto, and a tube 2-2 having an intermediate layer laminated thereto and a surface lubricating layer laminated thereto were obtained in the same manner as in Example 1, except that the mass ratio of polyester resin 1 to polyurethane resin was 50 / 50.

[0163] Example 3 A tube 3-1 having an intermediate layer laminated thereto, and a tube 3-2 having an intermediate layer laminated thereto and a surface lubricating layer laminated thereto were obtained in the same manner as in Example 1, except that the mass ratio of polyester resin 1 to polyurethane resin was 30 / 70.

[0164] Example 4 Except for using polyester resin 2 instead of polyester resin 1, the same procedure as in Example 2 was used to obtain a tube 4-1 having an intermediate layer laminated thereto, and a tube 4-2 having an intermediate layer laminated thereto and a surface lubricating layer laminated thereto.

[0165] Example 5 Except for using polyester resin 3 instead of polyester resin 1, a tube 5-1 having an intermediate layer laminated thereto and a tube 5-2 having an intermediate layer laminated thereto and a surface lubricating layer laminated thereto were obtained in the same manner as in Example 2.

[0166] Example 6 Except for using polyester resin 4 instead of polyester resin 1, a tube 6-1 having an intermediate layer laminated thereto and a tube 6-2 having an intermediate layer laminated thereto and a surface lubricating layer laminated thereto were obtained in the same manner as in Example 2.

[0167] Example 7 Except for using polyester resin 5 instead of polyester resin 1, the same procedure as in Example 2 was used to obtain a tube 7-1 having an intermediate layer laminated thereto, and a tube 7-2 having an intermediate layer laminated thereto and a surface lubricating layer laminated thereto.

[0168] Example 8 Except for using polyester resin 6 instead of polyester resin 1, the same procedure as in Example 2 was used to obtain tube 8-1 having an intermediate layer laminated thereto, and tube 8-2 having an intermediate layer laminated thereto and a surface lubricating layer laminated thereto.

[0169] Example 9 Except for using polyester resin 7 instead of polyester resin 1, the same procedure as in Example 2 was used to obtain tube 9-1 having an intermediate layer laminated thereto, and tube 9-2 having an intermediate layer laminated thereto and a surface lubricating layer laminated thereto.

[0170] Example 10 Except for using polyester resin 8 instead of polyester resin 1, a tube 10-1 having an intermediate layer laminated thereto and a tube 10-2 having an intermediate layer laminated thereto and a surface lubricating layer laminated thereto were obtained in the same manner as in Example 2.

[0171] Example 11 Except for using polyester resin 9 instead of polyester resin 1, the same procedure as in Example 2 was used to obtain a tube 11-1 having an intermediate layer laminated thereto, and a tube 11-2 having an intermediate layer laminated thereto and a surface lubricating layer laminated thereto.

[0172] Example 12 Except for using polyester resin 10 instead of polyester resin 1, a tube 12-1 having an intermediate layer laminated thereto and a tube 12-2 having an intermediate layer laminated thereto and a surface lubricating layer laminated thereto were obtained in the same manner as in Example 2.

[0173] Comparative Example 1 A tube 13-1 having an intermediate layer laminated thereon and a tube 13-2 having an intermediate layer laminated with a surface lubricating layer were obtained in the same manner as in Example 1, except that no polyurethane resin was used.

[0174] Comparative Example 2 A tube 14-1 having an intermediate layer laminated thereon and a tube 14-2 having an intermediate layer and a surface lubricating layer laminated thereon were obtained in the same manner as in Example 1, except that polyester resin 1 was not used.

[0175] Comparative Example 3 Except for using Vylonal (registered trademark) MD-2000 (manufactured by Toyobo Co., Ltd., (meth)acrylic modification rate 0%, sulfonic acid group-containing polyester resin, water-dispersible type) instead of polyester resin 1, a tube 15-1 laminated with an intermediate layer and a tube 15-2 laminated with an intermediate layer and a surface lubricating layer were obtained in the same manner as in Example 2.

[0176] Comparative Example 4 A tube 16-1 having an intermediate layer laminated thereto, and a tube 16-2 having an intermediate layer laminated thereto and a surface lubricating layer laminated thereto were obtained in the same manner as in Example 2, except that Elitel (registered trademark) KT-8803 (manufactured by Unitika Ltd., (meth)acrylic modification rate 0%, carboxyl group-containing polyester resin, water-dispersible type) was used instead of polyester resin 1.

[0177] Comparative Example 5 Except for using unmodified polyester resin 11 instead of polyester resin 1, a tube 17-1 laminated with an intermediate layer and a tube 17-2 laminated with an intermediate layer and a surface lubricating layer were obtained in the same manner as in Example 2.

[0178] [evaluation] <Kinematic friction coefficient> For the tubes 1-2 to 17-2 in which the intermediate layer and the surface lubricating layer were laminated, the dynamic friction coefficient was evaluated using a friction measuring device (Handy Tribomaster TL201Ts, manufactured by Trinity Labs) 20 shown in FIG. 1 according to the following method.

[0179] That is, a core material 18 was inserted into a tube 16 to prepare a tube sample (outer diameter 0.9 mm × length 200 mm) for evaluation. This tube sample was laid lengthwise and fixed in a petri dish 12, and immersed in ion-exchanged water at a height that covered the entire tube sample. This petri dish 12 was placed on a moving table 15 of a friction tester 20 shown in FIG. 1. A terminal (φ10 mm) 13 made of hydrogenated styrene-based thermoplastic elastomer (SEBS) was brought into contact with the tube sample, and a load 14 of 200 g was applied to the terminal. The coefficient of dynamic friction (unit: μN) was measured when the moving table 15 was moved back and forth horizontally 100 times with a sliding distance of 20 mm and a sliding speed of 16.7 mm / sec.

[0180] <Checking the coating of the middle layer> Leucomalachite green (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) was dissolved in ion-exchanged water to a concentration of 1% by mass to prepare dyeing solution A. Next, the same test as the above-mentioned <Kinematic friction coefficient> was performed on the tubes 1-1 to 18-1 with laminated intermediate layers prepared in the above-mentioned <Sample preparation (formation of intermediate layer)>, and the tubes (outer diameter 0.9 mm x length 200 mm) after this test were immersed in dyeing solution A for 30 minutes. Thereafter, the surface of the tube was washed with ion-exchanged water, and the entire outer surface of the tube after washing was visually inspected, and the degree of dyeing was evaluated according to the following criteria. The areas where dyeing was observed indicate areas where the substrate was exposed. In other words, the fewer areas where dyeing was observed, the better the adhesion between the substrate and the intermediate layer. If the following evaluation is rated as ◎ to ○, the product is usable: ◎: No staining observed on the entire outer surface of the tube ○: 10% to less than 30% of the entire outer surface of the tube is stained △: 30% to less than 50% of the entire outer surface of the tube is stained ×: 50% or more of the entire outer surface of the tube is stained.

[0181] <Confirmation of the coating of the surface lubricant layer> Congo red (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) was dissolved in ion-exchanged water to a concentration of 1% by mass to prepare staining solution B. Next, the above-mentioned [dynamic friction coefficient] test was performed on the tubes 1-2 to 18-2, which were prepared in <Sample preparation (surface lubricant layer)> and had the intermediate layer and surface lubricant layer laminated thereon, and the tubes (outer diameter 0.9 mm x length 200 mm) after this test were immersed in staining solution B for 30 minutes. Thereafter, the surface of the tube was washed with ion-exchanged water, and the entire outer surface of the tube after washing was visually confirmed, and the degree of dyeing was evaluated according to the following criteria. The areas where dyeing was observed indicate that the block copolymer was present (coated). In other words, the more areas where dyeing was observed, the better the adhesion between the intermediate layer and the surface lubricant layer. If the following evaluation is ◎ to ○, it is practical: ◎: Less than 5% of the entire outer surface of the tube is uncolored ○: Uncolored areas on the entire outer surface of the tube are between 5% and 10%. △: Uncolored areas on the entire outer surface of the tube are more than 10% but less than 30% ×: Unstained areas on the entire outer surface of the tube exceed 30%.

[0182] The composition of the (meth)acrylic modified polyester resin and the composition of the intermediate layer are shown in Table 2 below, along with the evaluation results of the dynamic friction coefficient, the coating film confirmation of the intermediate layer, and the coating film confirmation of the surface lubricating layer.

[0183] [Table 2]

[0184] As is clear from Table 2 above, the tubes of Examples 1 to 12 had excellent adhesion between the substrate and intermediate layer, and between the intermediate layer and surface lubricating layer, and the durability of the surface lubricating layer was excellent.

[0185] In addition, the following evaluations were performed using tubes 1-1 to 3-1 and 13-1 to 14-1, in which an intermediate layer was formed in the same manner as in Examples 1 to 3 and Comparative Examples 1 to 2 obtained above, as well as catheter tubes 1 to 3 in which an intermediate layer and a surface lubricating layer were formed, and comparative catheter tubes 1 to 2.

[0186] <Elastic modulus of middle layer> Tubes 1-1 to 3-1 and tubes 13-1 to 14-1 with laminated intermediate layers prepared in the above <Sample preparation (formation of intermediate layer)> were cut into 10 mm pieces. Next, the samples were placed on a scanning probe microscope (AFM5200S, Hitachi High-Tech Science Corporation) and force mapping measurements were performed in a 500 nm x 500 nm field of view using a cantilever probe (SI-DF3P2, Hitachi High-Tech Science Corporation) to calculate the elastic modulus of the intermediate layer laminated on the tube surface. The elastic modulus was calculated by fitting the indentation-load curve obtained by the measurement to a theoretical curve obtained from the spring constant and curvature radius specific to the cantilever probe.

[0187] In this evaluation, the cantilever probe had a spring modulus of 3.2 N / m, the tip shape had a radius of curvature of 4.68 nm, and the Poisson's ratio of the sample was set to 0.3.

[0188] <Sliding durability test> A bent tube made of polytetrafluoroethylene (PTFE) with an inner diameter of 1 mm filled with ion-exchanged water was prepared as shown in Figure 2, and a guidewire was inserted into the tube. As shown in Figure 2, the tube had a total length of 370 mm, and five wavy bends with a radius of curvature (R) of 7.5 mm were provided. The bends were formed by bending a straight section of 24 mm to have a radius of curvature of 7.5 mm.

[0189] Separately, a catheter tube (Terumo Corporation, Progreat (registered trademark) 2.7 Fr. before hydrophilic coating) was prepared, and an intermediate layer and a surface lubricant layer were laminated in a region up to 70 cm from the tip in the same manner as in <Sample preparation (formation of intermediate layer)> and <Sample preparation (formation of surface lubricant layer)> in Examples 1 to 3 and Comparative Examples 1 and 2, to produce catheter tubes 1 to 3 and comparative catheter tubes 1 to 2.

[0190] These catheter tubes were inserted into the guide wire inserted into the bent tube. At this time, the tips of the guide wire and the catheter tube were inserted into the bent PTFE tube until they reached the exit of the bent PTFE tube. In this way, each catheter tube was inserted back and forth 50 times into the guide wire in the bent PTFE tube at a moving distance of 40 mm and an insertion speed of 500 mm / min, and then the maximum resistance value at that time was measured using a tensile tester (AG-10N, manufactured by Shimadzu Corporation). The sliding resistance increase rate was calculated from the obtained maximum resistance value at the first reciprocation and the maximum resistance value at the 50th reciprocation using the following formula.

[0191]

number

[0192] Based on the calculated rate of increase in sliding resistance, the sliding durability of the catheter tube was evaluated according to the following criteria. ○: Sliding resistance increase rate is 0% or more and less than 30% ×: The sliding resistance increase rate is 30% or more.

[0193] The evaluation results of the elastic modulus and the rate of increase in sliding resistance are shown in Table 3 below.

[0194] [Table 3]

[0195] As is clear from Table 3, the catheter tubes of Examples 13 to 15 had an excellent balance between elastic modulus (flexibility) and sliding durability. Comparative Example 6 is a catheter tube in which the intermediate layer contains only a (meth)acrylic modified polyester resin, but both flexibility and sliding durability were reduced. Comparative Example 7 is a catheter tube in which the intermediate layer contains only a polyurethane resin, but although it had flexibility, it had reduced sliding durability.

[0196] This application is based on Japanese Patent Application No. 2019-168683 filed on September 17, 2019, the disclosure of which is incorporated herein by reference in its entirety.

Claims

1. A substrate having a surface part made of polyester resin; an intermediate layer formed on at least a portion of a surface of the substrate and containing a (meth)acrylic-modified polyester resin and a polyurethane resin; a surface lubricating layer formed on the upper part of the intermediate layer and including a block copolymer having a structural unit (A) derived from a hydrophobic monomer and a structural unit (B) derived from a hydrophilic monomer; Equipped with At least one of the hydrophobic monomer and the hydrophilic monomer has a (meth)acryloyl group, the (meth)acrylic modification rate of the (meth)acrylic-modified polyester resin is more than 10 mol % and 60 mol % or less based on the total number of moles of monomers constituting the (meth)acrylic-modified polyester resin; The (meth)acrylic modified polyester resin contains terephthalic acid and isophthalic acid as polyvalent carboxylic acid components, The medical device, wherein a molar ratio of the constituent units derived from terephthalic acid to the constituent units derived from isophthalic acid is 1.5 or more and 4.5 or less.

2. 2. The medical device according to claim 1, wherein a mass ratio of the (meth)acrylic-modified polyester resin to the polyurethane resin in the intermediate layer is (meth)acrylic-modified polyester resin / polyurethane resin=70 / 30 to 30 / 70.

3. The medical device according to claim 1 or 2, wherein the content of the constitutional unit derived from terephthalic acid is 12.5 to 40 mol % relative to the total mole number of the monomer constituting the (meth)acrylic resin segment and the monomer constituting the polyester resin segment.

4. The medical device according to any one of claims 1 to 3, wherein the hydrophobic monomer comprises at least one selected from the group consisting of glycidyl acrylate, glycidyl methacrylate, 3,4-epoxycyclohexylmethyl acrylate, 3,4-epoxycyclohexylmethyl methacrylate, and β-methylglycidyl methacrylate.

5. The medical device according to any one of claims 1 to 4, wherein the hydrophilic monomer comprises at least one selected from the group consisting of N,N-dimethylacrylamide, N,N-diethylacrylamide, acrylamide, 2-hydroxyethyl acrylate, and 2-hydroxyethyl methacrylate.

6. The medical device according to any one of claims 1 to 5, wherein the medical device is a catheter.

Citation Information

Patent Citations

  • Laminated film

    JP2002273834A

  • Medical tool

    JP2018000746A

  • Layered product

    WO2016052133A1